uniQure NV (NASDAQ:QURE) Receives $27.75 Average PT from Brokerages
Shares of uniQure NV (NASDAQ:QURE) have received a consensus recommendation of “Buy” from the eleven ratings firms that are presently covering the stock. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $27.75.
Several equities research analysts have recently weighed in on the company. Piper Jaffray Cos. reaffirmed a “buy” rating on shares of uniQure NV in a research report on Thursday, June 30th. Cowen and Company reaffirmed a “buy” rating on shares of uniQure NV in a research report on Thursday, July 28th. Leerink Swann reaffirmed an “outperform” rating and issued a $27.00 target price on shares of uniQure NV in a research report on Monday, August 29th. WallachBeth Capital decreased their target price on uniQure NV from $60.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, June 15th. Finally, HC Wainwright assumed coverage on uniQure NV in a research report on Thursday, August 4th. They issued a “buy” rating and a $21.00 target price for the company.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Point72 Asset Management L.P. increased its position in uniQure NV by 105.7% in the second quarter. Point72 Asset Management L.P. now owns 562,447 shares of the company’s stock worth $4,145,000 after buying an additional 288,982 shares in the last quarter. Landscape Capital Management L.L.C. increased its position in uniQure NV by 304.2% in the first quarter. Landscape Capital Management L.L.C. now owns 154,100 shares of the company’s stock worth $1,831,000 after buying an additional 115,975 shares in the last quarter. Acadian Asset Management LLC purchased a new position in uniQure NV during the second quarter worth approximately $804,000. Renaissance Technologies LLC increased its position in uniQure NV by 95.6% in the first quarter. Renaissance Technologies LLC now owns 205,800 shares of the company’s stock worth $2,445,000 after buying an additional 100,600 shares in the last quarter. Finally, Spark Investment Management LLC increased its position in uniQure NV by 28.5% in the second quarter. Spark Investment Management LLC now owns 380,400 shares of the company’s stock worth $2,803,000 after buying an additional 84,400 shares in the last quarter. 32.38% of the stock is currently owned by institutional investors.
uniQure NV (NASDAQ:QURE) opened at 7.58 on Thursday. The firm’s 50-day moving average price is $8.00 and its 200 day moving average price is $9.96. The firm’s market cap is $190.48 million. uniQure NV has a 52-week low of $6.68 and a 52-week high of $22.79.
uniQure NV (NASDAQ:QURE) last announced its quarterly earnings results on Thursday, August 25th. The company reported ($0.87) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.89) by $0.02. uniQure NV had a negative return on equity of 61.96% and a negative net margin of 537.62%. On average, equities research analysts forecast that uniQure NV will post ($3.70) EPS for the current year.
About uniQure NV
uniQure N.V. is engaged in the field of gene therapy. The Company is engaged in the discovery, development and commercialization of gene therapies. It has a technology platform that uses as the basis for collaborative product candidates across approximately three therapeutic focus areas, such as Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
Receive News & Stock Ratings for uniQure NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for uniQure NV and related stocks with our FREE daily email newsletter.